Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bisantrene regulatory update

Update said FDA granted Orphan Drug designation to UPI-928 to treat acute myelogenous leukemia (AML). Update said it is preparing

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE